Bank of America’s Nemaura Medical, Inc. Common Stock NMRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-138
Closed -$1K 8945
2021
Q4
$1K Buy
138
+17
+14% +$92 ﹤0.01% 8115
2021
Q3
$1K Sell
121
-1,597
-93% -$11.5K ﹤0.01% 8037
2021
Q2
$17K Sell
1,718
-9,837
-85% -$93.9K ﹤0.01% 7183
2021
Q1
$88K Buy
11,555
+7,876
+214% +$52.1K ﹤0.01% 6447
2020
Q4
$13K Buy
3,679
+723
+24% +$2.79K ﹤0.01% 6678
2020
Q3
$10K Sell
2,956
-9,034
-75% -$52.8K ﹤0.01% 6455
2020
Q2
$111K Buy
11,990
+10,467
+687% +$74.7K ﹤0.01% 5621
2020
Q1
$9K Buy
+1,523
New +$7.02K ﹤0.01% 6397
2018
Q2
Sell
-2,083
Closed -$95K 7393
2018
Q1
$95K Buy
+2,083
New +$110K ﹤0.01% 5761

Other funds holding NMRD

Bank of America's NMRD Position: Q1 2022 in Review

Bank of America sold out of Nemaura Medical, Inc. Common Stock (NMRD) in Q1 2022, closing a stake of 138 shares — an estimated $1K sold.

Bank of America first reported a position in NMRD in Q1 2018 and held it in 9 quarters. The position peaked at $111K in Q2 2020. 17 funds tracked by Wall St. Rank hold NMRD as of Q1 2022.

  • Bank of America reported no remaining Nemaura Medical, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Bank of America sold 138 Nemaura Medical, Inc. Common Stock shares in Q1 2022, an estimated $1K.
  • Bank of America first reported a position in Nemaura Medical, Inc. Common Stock in Q1 2018 and held it in 9 quarters.
  • Bank of America's Nemaura Medical, Inc. Common Stock position peaked at $111K in Q2 2020.
  • 17 funds tracked by Wall St. Rank held Nemaura Medical, Inc. Common Stock as of Q1 2022.

Based on Bank of America's 13F filing for Q1 2022, filed 16 May 2022.